...
首页> 外文期刊>Molecules >Mixed Antimony(V) Complexes with Different Sugars to Modulate the Oral Bioavailability of Pentavalent Antimonial Drugs
【24h】

Mixed Antimony(V) Complexes with Different Sugars to Modulate the Oral Bioavailability of Pentavalent Antimonial Drugs

机译:不同糖类的混合锑(V)配合物可调节五价锑药物的口服生物利用度

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Previous studies have shown that the association of the drug meglumine antimoniate (MA) with β-cyclodextrin can improve its bioavailability by the oral route. In this work, ribose and maltose were investigated for their ability to form mixed or association complexes with MA, release MA and modulate the serum levels of Sb after oral administration in mice. Analysis of the MA/ribose composition by high performance liquid chromatography coupled to mass spectrometry (LCMS-IT-TOF) revealed the presence of mixed meglumine-Sb-ribose and Sb-ribose complexes. Analysis of the MA/maltose composition suggested the formation of MA-maltose association compounds. Circular dichroism characterization of these compositions following dilution in water at 37 °C suggested a partial and slow dissociation of the association compounds. When the MA/ribose composition was administered orally and compared to MA, the serum concentration of Sb was significantly lower after 1 h and greater after 3 h. On the other hand, the MA/maltose composition showed similar serum Sb concentration after 1 h and higher level of Sb after 3 h, when compared to MA. In conclusion, the present study has demonstrated the formation of mixed or association complexes of MA with sugars, such as maltose and ribose, which promoted sustained serum level of Sb after oral administration.
机译:先前的研究表明,药物葡甲胺锑酸盐(MA)与β-环糊精的结合可以通过口服途径改善其生物利用度。在这项工作中,对核糖和麦芽糖与MA形成混合或缔合复合物,释放MA以及调节小鼠口服后Sb血清水平的能力进行了研究。通过与质谱联用的高效液相色谱法(LCMS-IT-TOF)对MA /核糖组成进行分析,发现存在混合葡甲胺-Sb-核糖和Sb-核糖复合物。对MA /麦芽糖组成的分析表明形成了MA-麦芽糖缔合化合物。这些组合物在37°C水中稀释后的圆二色性表征表明缔合化合物部分解离缓慢。当口服MA /核糖组合物并与MA比较时,Sb的血清浓度在1小时后显着降低,而在3小时后升高。另一方面,与MA相比,MA /麦芽糖组合物在1小时后显示相似的血清Sb浓度,在3小时后显示较高的Sb水平。总之,本研究表明MA与糖(如麦芽糖和核糖)的混合或缔合复合物的形成,可促进口服后Sb的持续血清水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号